Today, I would like to show you a hopeful news: “The University Clinic of Navarra starts a new clinical trial to "cleanse" brain of Alzheimer”.
Indeed, a team of specialists, from the University Clinic of Navarre, has started a new clinical trial, to curb the cognitive deterioration, that causes Alzheimer's disease. This is a multi-centre research, in recruitment phase, involving centres in the United States and Europe. Currently, about 600,000 people suffer from this disease, in Spain.
The Universitary Clinic of Navarre
The current treatment is aimed at people with a slight cognitive deterioration, ie in the most incipient stages, in which the disease still does not affect the patients' daily lives. However, this new drug (Crenezumab) also includes people with mild-stage dementia, that is, those stages, in which the patient begins to have trouble, to perform its daily activities.
As eplains the Dr. Mario Riverol, a neurologist, at the Universitary Clinic of Navarra, specializing in Alzheimer's disease and principal investigator in this trial: "These are antibodies, that act on the Amyloid protein, which is deposited in the brains of patients with Alzheimer's, the main cause of the illness. The drug's function is to "clean" the brain's Amyloid, with the goal of stopping the course of the disease".
Dr. Mario Riverol
The Amyloid protein
Alzheimer's, which does not currently have a cure, --although there is treatment to reduce some symptoms--, it implies loss of memory, confusion and personality change. Worldwide, more than 47 million people suffer from dementia, of which Alzheimer's disease is the most common form.
From here, I would like to make my own tribute to all those persons, who suffer Alzheimer´s, all over the world.
I hope that the research, that I have talked to you about, can help many people.
Until my next post, kind regards,
Luis.
Sponsored by Costaluz Lawyers.
Please click below:
